+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Dynamics of Growth Hormone Secretion in Patients with Osteoporosis and in Patients with Osteoarthrosis

      a , a , b

      Hormone Research in Paediatrics

      S. Karger AG

      Osteoarthrosis, Growth hormone, Osteoporosis

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Basal plasma growth hormone levels as well as growth hormone levels during insulin-induced hypoglycemia have been studied in 19 cases with osteoporosis, in 34 patients with primary osteoarthrosis and in 19 control subjects. Women with primary osteoarthrosis had basal growth hormone levels significantly higher than control patients and patients with osteoporosis. The respective mean values and SE were: 4.9 ± 0.8 vs. 1.9 ± 0.8 and 1.3 ± 0.2, p < 0.025. During insulin-induced hypoglycemia the growth hormone levels rose to values which in osteoarthrotic women were significantly higher than in osteoporotics and in control subjects.

          Related collections

          Author and article information

          Horm Res Paediatr
          Hormone Research in Paediatrics
          S. Karger AG
          25 November 2008
          : 16
          : 6
          : 353-356
          aAfdeling Reumatologie, Academische Ziekenhuizen, Leuven; bLaboratorium voor Experimentele Geneeskunde, Rega Instituut, Leuven, Katholieke Universiteit Leuven, België
          179525 Horm Res 1982;16:353–356
          © 1982 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 4


          Comment on this article